From professional translators, enterprises, web pages and freely available translation repositories.
transderm lie pl ksteri.
transdermal patch.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
24 transderm lie pl ksteri
24 transdermal patches
Last Update: 2012-04-10
Usage Frequency: 4
Quality:
satur 1 transderm lo pl ksteri
contains 1 transdermal patch.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
paredz ti tikai transderm lai lietošanai
for transdermal use only
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
(satur vienu transderm lo pl ksteri)
sachet (contains 1 transdermal patch)
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
kartona k rba (satur 24 transderm los pl ksterus)
carton (containing 24 transdermal patches)
Last Update: 2012-04-10
Usage Frequency: 6
Quality:
kentera 3. 9 mg / 24 stundas, transderm lie pl ksteri
kentera 3.9 mg / 24 hours, transdermal patch
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
kentera 3. 9 mg / 24 stundas transderm lie pl ksteri oxybutynin
kentera 3.9 mg / 24 hours transdermal patch oxybutynin
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
paredz ti tikai transderm lai lietošanai nelietot, ja iepakojums ir boj ts.
for transdermal use only do not use if seal on sachet is broken.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
paredz ti tikai transderm lai lietošanai nelietot, ja tiešais iepakojums ir boj ts.
do not use if seal on sachet is broken
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
gr tniec ba pašreiz nav pietiekamu datu par oksibutin na transderm lo pl ksteru iedarb bu gr tniec m.
pregnancy there are no adequate data on the use of oxybutynin transdermal patch in pregnant women.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
paaugstin ta jut ba pret transderm lo pl ksteru akt vo vielu un/ vai jebkuru no pal gviel m.
hypersensitivity to the active substance or to any other excipients of the transdermal patch.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
ja jums ir aler ija pret medic nisko pl ksteri vai citiem transderm lajiem pl ksteriem, konsult jieties pie sava rsta.
if you are hypersensitive (allergic) to oxybutynin or any of the ingredients of kentera.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
plazmas oksibutin na koncentr cija samazin s 1 – 2 stundu laik p c transderm l pl kstera (- u) no emšanas.
plasma concentration of oxybutynin declines within 1 to 2 hours after removal of transdermal system(s).
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
transderm las oksibutin na ievad šanas rezult t tiek apiets ce š caur gremošanas traktu un akn m, t d j di samazinot n- dezetiloksibutin na metabol ta veidošanos.
transdermal administration of oxybutynin bypasses the first-pass gastrointestinal and hepatic metabolism, reducing the formation of the n-desethyl metabolite.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
transderm lie pl ksteri tiek individu li iepakoti ldpe/ pap ra lamin ta iepakojum un safas ti kast s ar pacienta kalend ru, pa 2, 8 vai 24 pl ksteriem katr.
the transdermal patches are individually contained in ldpe/ paper laminate sachets and supplied in patient calendar boxes of 2, 8 or 24 patches.
Last Update: 2012-04-10
Usage Frequency: 2
Quality: